Pigmented Lesion Treatment Market

Market Insights on Pigmented Lesion Treatment covering sales outlook, demand forecast & up-to-date key trends

Pigmented Lesion Treatment Market by Product, Lesion Type, End User & Region - Forecast 2022 – 2032

Pigmented Lesion Treatment Market Overview (2022-2032)

[268 Pages Report] The global market for pigmented lesion treatment was valued at US$ 3.1 Bn in 2021 and is anticipated to grow at a 7.7% CAGR during the forecast period (2022-2032). With a total market value share of around 72% as of 2021, dermatology clinics lead the pigmented lesions treatment market worldwide.

Market Outlook:

Data	Market Insight
Market Value 2021	US$ 3.1 Bn
Estimated market Value 2022	US$ 3.3 Bn
Estimated market Value 2032	US$ 7.0 Bn
CAGR of 2022-2032	7.7%
Market share of Top 5 countries	48.4%
Key Market players	Lumenis Ltd., Alma Laser Inc, Zeltic, El.En., Cutera, Sisram, Allergan Plc, Cynosure, Johnson & Johnson, Bausch Health group of companies, STRATA Skin Sciences, Solta Medical Inc., Lynton’s Laser Ltd., Lutronic Corporation, Fotona d.d., Sciton, Inc., Alma Laser

Skin conditions known as pigmented lesions are also known as melanocytic proliferations. Melanin, blood, or foreign pigment cause pigmented lesions to be brown, black, or blue in colour. Pigmented lesions on exposed skin that are developing or spreading can be a sign of skin cancer. Non-melanocytic and melanocytic pigmented lesions are divided into benign and malignant categories, respectively. Under a microscope, a malignant lesion is a tissue that looks aberrant and is more likely to be cancer tissue.

In order to prevent the spread and occurrence of malignant skin diseases, premalignant lesions should be removed. All forms of skin cancer can be avoided with early detection and careful lesion excision. Environmental and natural factors that contribute to pigment lesions include photodamage, which is brought on by prolonged exposure to ultraviolet (UV) radiation and causes problems with the skin and early ageing. A pigment lesion can affect people of almost any age. For pigmented lesions, a variety of laser treatments are available, including the MedLite and ErYAG lasers, which are both efficient and reasonably priced.

Don't pay for what you don't need

Customize your report by selecting specific countries or regions and save 30%!

Sales Analyses of Pigmented Lesion Treatment Market 2017-2021 Vs Market outlook for 2022-2032.

The pigmented lesion treatment market reached a value of US$ 3.1 Bn in 2021 and is anticipated to grow at a revenue CAGR of 7.7% during the following years (2022-2032). The pigmented lesion therapy market expanded historically between 2017 and 2021 at a CAGR of 6.3%.

In the year 2021, the global medical aesthetic market was valued at around US$ 13.7 Bn, and the pigmented lesion treatment market accounted for around 23% of that market.

The growing elderly population in nations is one of the major causes driving up demand for the treatment of pigmented lesions. Pigmented lesions are a common skin condition that can affect the face and other parts of the body. Endogenous and exogenous factors are also implicated in the development of pigmented lesions.

The emphasis is now being increased on discovering phenotypic features that can cause pigmented lesions for the prevention of such diseases at an earlier stage. In the coming years, the market is expected to experience profitable growth because of the accessibility, efficacy, and affordability of numerous laser technologies for the treatment of pigmented lesions.

The presence of well-established healthcare infrastructure for treating patients and existing leading players in the market enable efficient treatment for patients with post-inflammatory hyperpigmentation. Additionally, factors like rising aesthetic consciousness and the frequent prevalence of pigmented lesions support market demand over the predicted period. The demand for pigmented lesions is fuelled by persistent alcohol use patterns, a rise in synthetic cosmetics, and new drugs and treatments.

There are currently a variety of therapeutic drugs as well as laser treatments available to treat or erase the markings, and the market is booming as a result of the pharmaceutical industry players' rising preference for minimally invasive procedures. The main advantages of these therapies are their dependability and little to non-existent adverse effects.

The aforementioned elements are projected market drivers for the growth of pigmented lesion treatment throughout the predicted time frame.

Pigmented Lesion Treatment Market Download Report Brochure

What are the Opportunities for the Manufacturers Operating within the Global Pigmented Lesion Treatment Market to Expand in the future?

Major companies are being compelled to provide cutting-edge treatment modules that deliver excellent outcomes and are economical in response to the population's growing need for treatments and elimination of pigmented lesions. This demand is causing the market to rise. Key players now produce non-invasive, med-aesthetic devices that effectively treat the severe effects of pigmented lesion therapy thanks to research and development in the sector. Because they are comfortable and effective, these treatments quickly earn popularity and patients' trust.

A new line of pharmaceuticals and technologically advanced products with increased efficacy are currently being introduced through clinical trials and research projects by scientific organisations and pharmaceutical companies.

For instance, PiQo4 by Lumenis is suitable for all skin tones and can treat pigmentation. In order to get rid of undesirable tattoos and pigmented lesions, the collection applies Pico and Nano technologies to the skin. The equipment can treat a wide range of skin types and disorders because of its technique/procedure of four wavelengths, high intensity, and deep reach.

Picosecond lasers are more effective for treating individual lentigines, compared with other types of devices, the tremendous intensity of this wave can cause the cell to gasify, reducing the pigment particles inside to a condition of total dust, making them easier for metabolic cells to ingest and digest. Alternatively, it can alter the physical characteristics of particular pigment particles such that they do not seem coloured.

The aforementioned opportunities provide excellent chances for the makers and their products to establish a strong consumer base and grow in popularity, which will fuel the global pigmented lesion treatment market during the predicted years.

Sabyasachi Ghosh

Principal Consultant

Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst

What are the Possible Restraints that can Hamper the Growth of Pigmented Lesion Treatment Market During the Predicted Period?

Side effects of laser therapy, such as itching, redness, and swelling of the skin, as well as the possibility of hyperpigmentation, scarring, blistering and in rare cases, infections, are expected to be a significant constraint of the worldwide pigmented lesion treatment market over the forecast period.

Since Asian skin contains more epidermal melanin than other skin types, the population is more prone to suffer from unfavourable pigmentary reactions after laser surgery. Therefore, this factor can probably decline the growth of pigmented lesion treatment market in the Asian region over the forecast period.

The standard for the treatment of pigmented lesions is the nanosecond laser, however, patients with dark skin are more at risk for side effects such as post-inflammatory hyperpigmentation. There are options for treating superficial pigmented lesions using laser devices, such as intense pulsed light (IPL) or long-pulsed lasers, which cause fewer side effects than nanosecond lasers.

The aforementioned factors may function as possible barriers and slow down the expansion of pigmented lesion treatment market throughout the forthcoming years.

Country Wise Insights

Why Does the United States Dominate the Market for Pigmented Lesion Treatments in North America?

With a market share of 91.2% by the end of 2021, the United States totally dominates the North American pigmented lesion treatment market. Growing aesthetic consciousness among the public and an increase in the frequency of pigmented lesions in the country are the main reason behind this dominance.

For instance, the Skin Cancer Foundation reports that each year in the U.S., more than 5.4 million cases of non-melanoma skin cancer are reported, and more than 3.3 million people undergo treatment for it, which encourages the expansion of the pigmented lesion treatment market in North America.

Which Nation Dominates the Market for Pigmented Lesions Treatment in Europe?

As of 2021, Germany owned most of the market for pigmented lesions treatment in Europe, accounting for 14.8% of European market revenue share. In both Europe and the entire world, Germany boasts one of the top healthcare systems. It has grown in popularity as a well-liked medical travel destination in recent years. One of the most popular aesthetic procedures in the nation includes, treatment of lentigines, liposuction, breast augmentation, face & neck lifts, and eyelid adjustments. The rising demand for these procedures foresees strong future growth for the German pigmented lesion treatment market.

How is the Market for Pigmented Lesions Treatment in East Asia Being Led by Japan?

By the end of 2021, Japan owned roughly 34% of revenue share of the East Asian pigmented lesion treatment market due to the rising beauty consciousness among the population, and the quick entry of new companies into the market.

One of the fastest-growing markets for medical laser and energy devices is laser hair removal, which has shown tremendous growth in Japan. The use of lasers permanently eliminates the overall amount of body hair, unlike waxing, shaving, or applying lotions. Due to Japanese aesthetic standards, which place a high value on smooth, hairless skin, the demand for laser hair removal devices has increased more quickly in Japan than in North American and European nations. Along with treating wrinkles, lesions, and other sorts of skin damage, laser and other energy technologies have also been utilized to tighten skin.

Category Wise Insights

Which Product Dominates the Market for Pigmented Lesion Treatment Globally?

With a market share of around 42.3% as of 2021, lasers and energy-based devices dominated the global market for the treatment of pigmented lesions. The market for different laser devices is expected to expand due to the growing need for treatment processes with quicker recovery times, fewer post-treatment infections, less pain, decreased scarring, greater control over bleeding, and increased precision.

What Form of Lesion Application has led to the Growth of the Pigmented Lesion Treatment Market?

By maintaining a market share of about 33.5%, the freckle skin disorder was valued at US$ 1.0 Bn in 2021. Freckles are little brown spots that appear flat on sun-exposed skin; this condition is more prevalent in those with fair skin. Across all racial and ethnic groups, men are far more likely to have it than women. This is common in those who are exposed to UV rays. Other causes are estrogenic levels, genetic predisposition, and phototoxic drugs; genetic predisposition also sometimes, play a role in causing hyperpigmentation (freckles).

Why do Dermatology Clinics Hold the Majority of the End User Market Share for Pigmented Lesions Treatment Globally?

The size of the worldwide dermatology clinic market, which was US$2.2 Bn in 2021, is anticipated to grow at 8.0% CAGR in terms of revenue during the projected period. The main factors driving the market for dermatology clinics are the expansion of the pharmaceutical industry, the ageing of the population, the rise in skin-related disorders, the rapid technological advancements in laser and light-based skin treatments, the development of more effective skin digital imaging, and the rising demand for early dermatological condition diagnosis.

Competitive Landscape

The market for lasers used to treat pigmented lesions is competitive and fragmented, with a number of large manufacturers. A few dominant organisations control a large portion of the market, and over the projected period, a small number of growing businesses are anticipated to do the same.

The leading market participants such as Lumenis Ltd., Alma Laser Inc, Zeltic, El.En., Cutera, Sisram, Allergan Plc, Cynosure, and Johnson & Johnson are using a variety of growth tactics, including product launches, acquisitions, and partnerships, which are assisting in the expansion of the lasers in pigmented lesion treatment market on a global scale. For example,

In February 2019, Cutera Inc. introduced the 'Excel V+laser platform'. Excel V+ is a technology with increased power and treatment speed for vascular and pigment lesion complications.
In March 2022, Cynosure announced the release of the PicoSure Pro device. The first and only 755 nm picosecond laser that has received FDA clearance, PicoSure Pro, delivers energy in a trillionth of a second using pressure rather than heat to provide safe and effective treatment to treat undesirable pigmentation and rejuvenate skin on all skin types.

Similarly, recent developments related to companies manufacturing lesion treatment devices have been tracked by the team at Future Market Insights, which are available in the full report.

Report Scope as per Pigmented Lesions Treatment Industry Analysis

Attribute	Details
Forecast Period	2022-2032
Historical Data Available for	2017-2021
Market Analysis	US$ Mn for Value
Key Regions Covered	North America, Latin America, Europe, East Asia, South Asia, Oceania and Middle East & Africa (MEA).
Key Countries Covered	USA, Canada, Brazil, Mexico, Argentina, Rest of Latin America, UK, Germany, Italy, Russia, Spain, France, BENELUX, Nordic Countries, Rest of Europe, Japan, China, South Korea, India, Thailand, Indonesia, Malaysia, Vietnam, Philippines, Rest of South Asia, Australia, New Zealand, Turkey, GCC, South Africa, Israel, North Africa and Rest of MEA.
Key Market Segments Covered	Product, lesion type, end user and region
Key Companies Profiled	Lumenis Ltd., Alma Laser Inc, Zeltic, El.En., Cutera, Sisram, Allergan Plc, Cynosure, Johnson & Johnson, Bausch Health group of companies, STRATA Skin Sciences, Solta Medical Inc., Lynton’s Laser Ltd., Lutronic Corporation, Fotona d.d., Sciton, Inc.
Pricing	Available upon Request

Key Market Segments Covered in Pigmented Lesion Treatment Industry Research

Product:

Lasers and Energy-Based Devices
Radiofrequency (RF) Devices
Micro-focused Ultrasound
Intense Pulsed Light Devices

Lesion Type:

Freckles
Lentigines
Melisma
Others

End User:

Dermatology Clinics
Beauty Clinics

Region:

North America
Latin America
Europe
East Asia
South Asia
Oceania
Middle East and Africa (MEA)

Frequently Asked Questions

What is the growth outlook for pigmented lesion treatment market?

The pigmented lesion treatment market is likely to secure a CAGR of 7.7% through 2032.

What is the current valuation of the pigmented lesion treatment market?

The pigmented lesion treatment market is likely to record a value of US$ 3.3 Bn in 2022.

By 2032, how much can the pigmented lesion treatment market grow?

The pigmented lesion treatment market size is estimated to cross US$ 7.0 Bn by 2032.

Which region is likely to lead the pigmented lesion treatment market?

North America is likely to lead the pigmented lesion treatment market with over 35% of the global revenue share.

Who are the key players in pigmented lesion treatment market?

Alma Lasers Ltd., Lumenis Ltd., Cynosure, Inc., Strata Skin Sciences Inc., Solta Medical Inc. are the major companies operating in pigmented lesion treatment market.

What is the study period of this market?

The pigmented lesion treatment market is studied from 2022 - 2032.

What was the growth rate of pigmented lesion treatment market in last 5 years?

The pigmented lesion treatment market grew at a CAGR rate of 6.3% from 2017 to 2021

Table of Content

1. Executive Summary

1.1. Global Market Outlook

1.2. Demand Side Trends

1.3. Supply Side Trends

1.4. Analysis and Recommendations

2. Market Overview

2.1. Market Coverage / Taxonomy

2.2. Market Definition / Scope / Limitations

2.3. Inclusions and Exclusions

3. Key Market Trends

3.1. Key Trends Impacting the Market

3.2. Product Innovation / Development Trends

4. Key Success Factors

4.1. Disease Epidemiology, by Region

4.2. Key Promotional Strategies by Manufacturers

4.3. Regulatory Landscape

4.4. Value Chain Analysis

4.5. Product Adoption Analysis

4.6. PESTEL Analysis

4.7. Porter’s Analysis

5. Market Background

5.1. Macro-Economic Factors

5.1.1. Global GDP Growth Outlook

5.1.2. Global Healthcare Outlook

5.2. Forecast Factors - Relevance & Impact

5.2.1. Top Companies Historical Growth

5.2.2. Increasing Healthcare Expenditure

5.2.3. Cost of products and treatments/surgeries

5.2.4. Availability of healthcare personnel

5.2.5. Rising Prevalence of disorders and Surgical Procedures

5.2.6. Better Healthcare Infrastructure

5.3. Market Dynamics

5.3.1. Drivers

5.3.2. Restraints

5.3.3. Opportunity Analysis

6. COVID-19 Crisis Analysis

6.1. COVID-19 and Impact Analysis

6.1.1. by Product

6.1.2. by Lesion Type

6.1.3. by End User

6.1.4. by Country

6.2. 2021 Market Scenario

7. Global Pigmented Lesion Treatment Market Volume (Units) Analysis 2017–2021 and Forecast, 2022–2032

7.1. Historical Market Volume (Units) Analysis, 2017–2021

7.2. Current and Future Market Volume (Units) Projections, 2022–2032

7.2.1. Y-o-Y Growth Trend Analysis

8. Global Pigmented Lesion Treatment Market - Pricing Analysis

8.1. Regional Pricing Analysis by Products

8.2. Pricing Break-up

8.2.1. Manufacturer Level Pricing

8.2.2. Distributor Level Pricing

8.3. Global Average Pricing Analysis Benchmark

8.4. Pricing Assumptions

9. Global Pigmented Lesion Treatment Market Demand (in Value or in US$ Mn) Analysis 2017–2021 and Forecast, 2022–2032

9.1. Historical Market Value (US$ Mn) Analysis, 2017–2021

9.2. Current and Future Market Value (US$ Mn) Projections, 2022–2032

9.2.1. Y-o-Y Growth Trend Analysis

9.2.2. Absolute $ Opportunity Analysis

10. Global Pigmented Lesion Treatment Market Analysis 2017–2021 and Forecast 2022–2032, by Product

10.1. Introduction / Key Findings

10.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis by Product, 2017–2021

10.3. Current and Future Market Size (US$ Mn) and Volume (Units) Analysis and Forecast by Product, 2022–2032

10.3.1. Laser and Energy Based Devices

10.3.2. Radiofrequency (RF) Devices

10.3.3. Micro-focused Ultrasound

10.3.4. Intense Pulse Light Devices

10.4. Market Attractiveness Analysis by Product

11. Global Pigmented Lesion Treatment Market Analysis 2017–2021 and Forecast 2022–2032, by Lesion Type

11.1. Introduction / Key Findings

11.2. Historical Market Size (US$ Mn) Analysis, by Lesion Type, 2017–2021

11.3. Current and Future Market Size (US$ Mn) Analysis and Forecast by Lesion Type, 2022–2032

11.3.1. Freckles

11.3.2. Lentigines

11.3.3. Melisma

11.3.4. Others

11.4. Market Attractiveness Analysis by Lesion Type

12. Global Pigmented Lesion Treatment Market Analysis 2017–2021 and Forecast 2022–2032, by End User

12.1. Introduction / Key Findings

12.2. Historical Market Size (US$ Mn) Analysis, by End User, 2017–2021

12.3. Current and Future Market Size (US$ Mn) Analysis Forecast by End User, 2022–2032

12.3.1. Dermatology Clinics /p>

12.3.2. Beauty Clinics

12.4. Market Attractiveness Analysis by End User

13. Global Pigmented Lesion Treatment Market Analysis 2017–2021 and Forecast 2022–2032, by Region

13.1. Introduction

13.2. Historical Market Size (US$ Mn) Analysis by Region, 2017–2021

13.3. Current and Future Market Value (US$ Mn) Analysis and Forecast, by Region 2022–2032

13.3.1. North America

13.3.2. Latin America

13.3.3. Europe

13.3.4. East Asia

13.3.5. South Asia

13.3.6. Oceania

13.3.7. The Middle East and Africa (MEA)

13.4. Market Attractiveness Analysis by Region

14. North America Pigmented Lesion Treatment Market Analysis 2017–2021 and Forecast 2022–2032

14.1. Introduction

14.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis by Market Taxonomy, 2017–2021

14.3. Current and Future Market Value (US$ Mn) and Volume (Units)Analysis and Forecast, by Market Taxonomy, 2022–2032

14.3.1. by Country

14.3.1.1. U.S.

14.3.1.2. Canada

14.3.2. by Product

14.3.3. by Lesion Type

14.3.4. by End User

14.4. Market Attractiveness Analysis

14.4.1. by Country

14.4.2. by Product

14.4.3. by Lesion Type

14.4.4. by End User

14.5. Market Trends

14.6. Drivers and Restraints - Impact Analysis

14.7. Key Players Intensity Mapping

14.8. Country Level Analysis & Forecast

14.8.1. U.S. Pigmented Lesion Treatment Market Analysis

14.8.1.1. Introduction

14.8.1.2. Market Analysis and Forecast by Market Taxonomy

14.8.1.2.1. by Product

14.8.1.2.2. by Lesion Type

14.8.1.2.3. by End User

14.8.2. Canada Pigmented Lesion Treatment Market Analysis

14.8.2.1. Introduction

14.8.2.2. Market Analysis and Forecast by Market Taxonomy

14.8.2.2.1. by Product

14.8.2.2.2. by Lesion Type

14.8.2.2.3. by End User

15. Latin America Pigmented Lesion Treatment Market Analysis 2017–2021 and Forecast 2022–2032

15.1. Introduction

15.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis by Market Taxonomy, 2017–2021

15.3. Current and Future Market Value (US$ Mn) and Volume (Units) Analysis and Forecast, by Market Taxonomy, 2022–2032

15.3.1. by Country

15.3.1.1. Mexico

15.3.1.2. Brazil

15.3.1.3. Argentina

15.3.1.4. Rest of Latin America

15.3.2. by Product

15.3.3. by Lesion Type

15.3.4. by End User

15.4. Market Attractiveness Analysis

15.4.1. by Country

15.4.2. by Product

15.4.3. by Lesion Type

15.4.4. by End User

15.5. Market Trends

15.6. Drivers and Restraints - Impact Analysis

15.7. Key Players’ Intensity Mapping

15.8. Country Level Analysis & Forecast

15.8.1. Mexico Pigmented Lesion Treatment Market Analysis

15.8.1.1. Introduction

15.8.1.2. Market Analysis and Forecast by Market Taxonomy

15.8.1.2.1. by Product

15.8.1.2.2. by Lesion Type

15.8.1.2.3. by End User

15.8.2. Brazil Pigmented Lesion Treatment Market Analysis

15.8.2.1. Introduction

15.8.2.2. Market Analysis and Forecast by Market Taxonomy

15.8.2.2.1. by Product

15.8.2.2.2. by Lesion Type

15.8.2.2.3. by End User

15.8.3. Argentina Pigmented Lesion Treatment Market Analysis

15.8.3.1. Introduction

15.8.3.2. Market Analysis and Forecast by Market Taxonomy

15.8.3.2.1. by Product

15.8.3.2.2. by Lesion Type

15.8.3.2.3. by End User

16. Europe Pigmented Lesion Treatment Market Analysis 2017–2021 and Forecast 2022–2032

16.1. Introduction

16.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis by Market Taxonomy, 2017–2021

16.3. Current and Future Market Value (US$ Mn) and Volume (Units) Analysis and Forecast, by Market Taxonomy, 2022–2032

16.3.1. by Country

16.3.1.1. Germany

16.3.1.2. Italy

16.3.1.3. France

16.3.1.4. U.K.

16.3.1.5. Spain

16.3.1.6. BENELUX

16.3.1.7. Russia

16.3.1.8. Nordic Countries

16.3.1.9. Rest of Europe

16.3.2. by Product

16.3.3. by Lesion Type

16.3.4. by End User

16.4. Market Attractiveness Analysis

16.4.1. by Country

16.4.2. by Product

16.4.3. by Lesion Type

16.4.4. by End User

16.5. Market Trends

16.6. Drivers and Restraints - Impact Analysis

16.7. Key Players Intensity Mapping

16.8. Country Level Analysis & Forecast

16.8.1. Germany Pigmented Lesion Treatment Market Analysis

16.8.1.1. Introduction

16.8.1.2. Market Analysis and Forecast by Market Taxonomy

16.8.1.2.1. by Product

16.8.1.2.2. by Lesion Type

16.8.1.2.3. by End User

16.8.2. Italy Pigmented Lesion Treatment Market Analysis

16.8.2.1. Introduction

16.8.2.2. Market Analysis and Forecast by Market Taxonomy

16.8.2.2.1. by Product

16.8.2.2.2. by Lesion Type

16.8.2.2.3. End User

16.8.3. France Pigmented Lesion Treatment Market Analysis

16.8.3.1. Introduction

16.8.3.2. Market Analysis and Forecast by Market Taxonomy

16.8.3.2.1. by Product

16.8.3.2.2. by Lesion Type

16.8.3.2.3. by End User

16.8.4. U.K. Pigmented Lesion Treatment Market Analysis

16.8.4.1. Introduction

16.8.4.2. Market Analysis and Forecast by Market Taxonomy

16.8.4.2.1. by Product

16.8.4.2.2. by Lesion Type

16.8.4.2.3. by End User

16.8.5. Spain Pigmented Lesion Treatment Market Analysis

16.8.5.1. Introduction

16.8.5.2. Market Analysis and Forecast by Market Taxonomy

16.8.5.2.1. by Product

16.8.5.2.2. by Lesion Type

16.8.5.2.3. by End User

16.8.6. BENELUX Pigmented Lesion Treatment Market Analysis

16.8.6.1. Introduction

16.8.6.2. Market Analysis and Forecast by Market Taxonomy

16.8.6.2.1. by Product

16.8.6.2.2. by Lesion Type

16.8.6.2.3. by End User

16.8.7. Russia Pigmented Lesion Treatment Market Analysis

16.8.7.1. Introduction

16.8.7.2. Market Analysis and Forecast by Market Taxonomy

16.8.7.2.1. by Product

16.8.7.2.2. by Lesion Type

16.8.7.2.3. by End User

16.8.8. Nordic Countries Pigmented Lesion Treatment Market Analysis

16.8.8.1. Introduction

16.8.8.2. Market Analysis and Forecast by Market Taxonomy

16.8.8.2.1. by Product

16.8.8.2.2. by Lesion Type

16.8.8.2.3. End User

17. East Asia Pigmented Lesion Treatment Market Analysis 2017–2021 and Forecast 2022–2032

17.1. Introduction

17.2. Historical Market End User (US$ Mn) and Volume (Units) Analysis by Market Taxonomy, 2017–2021

17.3. Current and Future Market Value (US$ Mn) and Volume (Units) Analysis and Forecast, by Market Taxonomy, 2022–2032

17.3.1. by Country

17.3.1.1. China

17.3.1.2. Japan

17.3.1.3. South Korea

17.3.2. by Product

17.3.3. by Lesion Type

17.3.4. by End User

17.4. Market Attractiveness Analysis

17.4.1. by Country

17.4.2. by Product

17.4.3. by Lesion Type

17.4.4. by End User

17.5. Market Trends

17.6. Drivers and Restraints - Impact Analysis

17.7. Key Players Intensity Mapping

17.8. Country Level Analysis & Forecast

17.8.1. China Pigmented Lesion Treatment Market Analysis

17.8.1.1. Introduction

17.8.1.2. Market Analysis and Forecast by Market Taxonomy

17.8.1.2.1. by Product

17.8.1.2.2. by Lesion Type

17.8.1.2.3. by End User

17.8.2. Japan Pigmented Lesion Treatment Market Analysis

17.8.2.1. Introduction

17.8.2.2. Market Analysis and Forecast by Market Taxonomy

17.8.2.2.1. by Product

17.8.2.2.2. by Lesion Type

17.8.2.2.3. by End User

17.8.3. South Korea Pigmented Lesion Treatment Market Analysis

17.8.3.1. Introduction

17.8.3.2. Market Analysis and Forecast by Market Taxonomy

17.8.3.2.1. by Product

17.8.3.2.2. by Lesion Type

17.8.3.2.3. by End User

18. South Asia Pigmented Lesion Treatment Market Analysis 2017–2021 and Forecast 2022–2032

18.1. Introduction

18.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis by Market Taxonomy, 2017–2021

18.3. Current and Future Market Value (US$ Mn) and Volume (Units) Analysis and Forecast, by Market Taxonomy, 2022–2032

18.3.1. by Country

18.3.1.1. India

18.3.1.2. Indonesia

18.3.1.3. Malaysia

18.3.1.4. Thailand

18.3.1.5. Philippines

18.3.1.6. Vietnam

18.3.1.7. Rest of South Asia

18.3.2. by Product

18.3.3. by Lesion Type

18.3.4. by End User

18.4. Market Attractiveness Analysis

18.4.1. by Country

18.4.2. by Product

18.4.3. by Lesion Type

18.4.4. by End User

18.5. Market Trends

18.6. Drivers and Restraints - Impact Analysis

18.7. Key Players Intensity Mapping

18.8. Country Level Analysis & Forecast

18.8.1. India Pigmented Lesion Treatment Market Analysis

18.8.1.1. Introduction

18.8.1.2. Market Analysis and Forecast by Market Taxonomy

18.8.1.2.1. by Product

18.8.1.2.2. by Lesion Type

18.8.1.2.3. by End User

18.8.2. Indonesia Pigmented Lesion Treatment Market Analysis

18.8.2.1. Introduction

18.8.2.2. Market Analysis and Forecast by Market Taxonomy

18.8.2.2.1. by Product

18.8.2.2.2. by Lesion Type

18.8.2.2.3. by End User

18.8.3. Malaysia Pigmented Lesion Treatment Market Analysis

18.8.3.1. Introduction

18.8.3.2. Market Analysis and Forecast by Market Taxonomy

18.8.3.2.1. by Product

18.8.3.2.2. by Lesion Type

18.8.3.2.3. by End User

18.8.4. Thailand Pigmented Lesion Treatment Market Analysis

18.8.4.1. Introduction

18.8.4.2. Market Analysis and Forecast by Market Taxonomy

18.8.4.2.1. by Product

18.8.4.2.2. by Lesion Type

18.8.4.2.3. by End User

18.8.5. Philippines Pigmented Lesion Treatment Market Analysis

18.8.5.1. Introduction

18.8.5.2. Market Analysis and Forecast by Market Taxonomy

18.8.5.2.1. by Product

18.8.5.2.2. by Lesion Type

18.8.5.2.3. by End User

18.8.6. Vietnam Pigmented Lesion Treatment Market Analysis

18.8.6.1. Introduction

18.8.6.2. Market Analysis and Forecast by Market Taxonomy

18.8.6.2.1. by Product

18.8.6.2.2. by Lesion Type

18.8.6.2.3. by End User

19. Oceania Pigmented Lesion Treatment Market 2017-2021 and Forecast 2022-2032

19.1. Introduction

19.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis by Market Taxonomy, 2017–2021

19.3. Current and Future Market Value (US$ Mn) and Volume (Units) Analysis and Forecast, by Market Taxonomy, 2022–2032

19.3.1. by Country

19.3.1.1. Australia

19.3.1.2. New Zealand

19.3.2. by Product

19.3.3. by Lesion Type

19.3.4. by End User

19.4. Market Attractiveness Analysis

19.4.1. by Country

19.4.2. by Product

19.4.3. by Lesion Type

19.4.4. by End User

19.5. Key Market Participants - Intensity Mapping

19.6. Drivers and Restraints - Impact Analysis

19.7. Key Players Intensity Mapping

19.8. Country Level Analysis & Forecast

19.8.1. Australia Pigmented Lesion Treatment Market Analysis

19.8.1.1. Introduction

19.8.1.2. Market Analysis and Forecast by Market Taxonomy

19.8.1.2.1. by Product

19.8.1.2.2. by Lesion Type

19.8.1.2.3. by End User

19.8.2. New Zealand Pigmented Lesion Treatment Market Analysis

19.8.2.1. Introduction

19.8.2.2. Market Analysis and Forecast by Market Taxonomy

19.8.2.2.1. by Product

19.8.2.2.2. by Lesion Type

19.8.2.2.3. by End User

20. Middle East and Africa (MEA) Pigmented Lesion Treatment Market Analysis 2017–2021 and Forecast 2022–2032

20.1. Introduction

20.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis by Market Taxonomy, 2017–2021

20.3. Current and Future Market Value (US$ Mn) and Volume (Units) Analysis and Forecast, by Market Taxonomy, 2022–2032

20.3.1. by Country

20.3.1.1. GCC Countries

20.3.1.2. Turkey

20.3.1.3. South Africa

20.3.1.4. Israel

20.3.1.5. North Africa

20.3.1.6. Rest of Middle East and Africa

20.3.2. by Product

20.3.3. by Lesion Type

20.3.4. by End User

20.4. Market Attractiveness Analysis

20.4.1. by Country

20.4.2. by Product

20.4.3. by Lesion Type

20.4.4. by End User

20.5. Market Trends

20.6. Drivers and Restraints - Impact Analysis

20.7. Key Players Intensity Mapping

20.8. Country Level Analysis & Forecast

20.8.1. GCC Countries Pigmented Lesion Treatment Market Analysis

20.8.1.1. Introduction

20.8.1.2. Market Analysis and Forecast by Market Taxonomy

20.8.1.2.1. by Product

20.8.1.2.2. by Lesion Type

20.8.1.2.3. by End User

20.8.2. Turkey Pigmented Lesion Treatment Market Analysis

20.8.2.1. Introduction

20.8.2.2. Market Analysis and Forecast by Market Taxonomy

20.8.2.2.1. by Product

20.8.2.2.2. by Lesion Type

20.8.2.2.3. by End User

20.8.3. South Africa Pigmented Lesion Treatment Market Analysis

20.8.3.1. Introduction

20.8.3.2. Market Analysis and Forecast by Market Taxonomy

20.8.3.2.1. by Product

20.8.3.2.2. by Lesion Type

20.8.3.2.3. by End User

20.8.4. Israel Pigmented Lesion Treatment Market Analysis

20.8.4.1. Introduction

20.8.4.2. Market Analysis and Forecast by Market Taxonomy

20.8.4.2.1. by Product

20.8.4.2.2. by Lesion Type

20.8.4.2.3. by End User

20.8.5. North Africa Pigmented Lesion Treatment Market

20.8.5.1. Introduction

20.8.5.2. Market Analysis and Forecast by Market Taxonomy

20.8.5.2.1. by Product

20.8.5.2.2. by Lesion Type

20.8.5.2.3. by End User

21. Market Structure Analysis

21.1. Market Analysis by Tier of Companies

21.2. Market Share Analysis of Top Players

21.3. Market Presence Analysis

22. Competition Analysis

22.1. Competition Dashboard

22.2. Competition Benchmarking

22.3. Competition Deep Dive

22.3.1. Cutera

22.3.1.1. Overview

22.3.1.2. Product Portfolio

22.3.1.3. Sales Footprint

22.3.1.4. Key Financials

22.3.1.5. SWOT Analysis

22.3.1.6. Strategy Overview

22.3.1.6.1. Marketing Strategy

22.3.1.6.2. Product Strategy

22.3.1.6.3. Channel Strategy

22.3.2. El.En

22.3.2.1. Overview

22.3.2.2. Product Portfolio

22.3.2.3. Sales Footprint

22.3.2.4. Key Financials

22.3.2.5. SWOT Analysis

22.3.2.6. Strategy Overview

22.3.2.6.1. Marketing Strategy

22.3.2.6.2. Product Strategy

22.3.2.6.3. Channel Strategy

22.3.3. Sisram

22.3.3.1. Overview

22.3.3.2. Product Portfolio

22.3.3.3. Sales Footprint

22.3.3.4. Key Financials

22.3.3.5. SWOT Analysis

22.3.3.6. Strategy Overview

22.3.3.6.1. Marketing Strategy

22.3.3.6.2. Product Strategy

22.3.3.6.3. Channel Strategy

22.3.4. Allergan Plc

22.3.4.1. Overview

22.3.4.2. Product Portfolio

22.3.4.3. Sales Footprint

22.3.4.4. Key Financials

22.3.4.5. SWOT Analysis

22.3.4.6. Strategy Overview

22.3.4.6.1. Marketing Strategy

22.3.4.6.2. Product Strategy

22.3.4.6.3. Channel Strategy

22.3.5. Cynosure

22.3.5.1. Overview

22.3.5.2. Product Portfolio

22.3.5.3. Sales Footprint

22.3.5.4. Key Financials

22.3.5.5. SWOT Analysis

22.3.5.6. Strategy Overview

22.3.5.6.1. Marketing Strategy

22.3.5.6.2. Product Strategy

22.3.5.6.3. Channel Strategy

22.3.6. Johnson and Johnson

22.3.6.1. Overview

22.3.6.2. Product Portfolio

22.3.6.3. Sales Footprint

22.3.6.4. Key Financials

22.3.6.5. SWOT Analysis

22.3.6.6. Strategy Overview

22.3.6.6.1. Marketing Strategy

22.3.6.6.2. Product Strategy

22.3.6.6.3. Channel Strategy

22.3.7. Bausch Health Group of Companies

22.3.7.1. Overview

22.3.7.2. Product Portfolio

22.3.7.3. Sales Footprint

22.3.7.4. Key Financials

22.3.7.5. SWOT Analysis

22.3.7.6. Strategy Overview

22.3.7.6.1. Marketing Strategy

22.3.7.6.2. Product Strategy

22.3.7.6.3. Channel Strategy

22.3.8. STRATA Skin Sciences

22.3.8.1. Overview

22.3.8.2. Product Portfolio

22.3.8.3. Sales Footprint

22.3.8.4. Key Financials

22.3.8.5. SWOT Analysis

22.3.8.6. Strategy Overview

22.3.8.6.1. Marketing Strategy

22.3.8.6.2. Product Strategy

22.3.8.6.3. Channel Strategy

22.3.9. Solta Medical Inc.

22.3.9.1. Overview

22.3.9.2. Product Portfolio

22.3.9.3. Sales Footprint

22.3.9.4. Key Financials

22.3.9.5. SWOT Analysis

22.3.9.6. Strategy Overview

22.3.9.6.1. Marketing Strategy

22.3.9.6.2. Product Strategy

22.3.9.6.3. Channel Strategy

22.3.10. Lynton Lasers Ltd.

22.3.10.1. Overview

22.3.10.2. Product Portfolio

22.3.10.3. Sales Footprint

22.3.10.4. Key Financials

22.3.10.5. SWOT Analysis

22.3.10.6. Strategy Overview

22.3.10.6.1. Marketing Strategy

22.3.10.6.2. Product Strategy

22.3.10.6.3. Channel Strategy

22.3.11. Lutronic Corporation

22.3.11.1. Overview

22.3.11.2. Product Portfolio

22.3.11.3. Sales Footprint

22.3.11.4. Key Financials

22.3.11.5. SWOT Analysis

22.3.11.6. Strategy Overview

22.3.11.6.1. Marketing Strategy

22.3.11.6.2. Product Strategy

22.3.11.6.3. Channel Strategy

22.3.12. Fotona d.d

22.3.12.1. Overview

22.3.12.2. Product Portfolio

22.3.12.3. Sales Footprint

22.3.12.4. Key Financials

22.3.12.5. SWOT Analysis

22.3.12.6. Strategy Overview

22.3.12.6.1. Marketing Strategy

22.3.12.6.2. Product Strategy

22.3.12.6.3. Channel Strategy

22.3.13. Sciton, Inc.

22.3.13.1. Overview

22.3.13.2. Product Portfolio

22.3.13.3. Sales Footprint

22.3.13.4. Key Financials

22.3.13.5. SWOT Analysis

22.3.13.6. Strategy Overview

22.3.13.6.1. Marketing Strategy

22.3.13.6.2. Product Strategy

22.3.13.6.3. Channel Strategy

23. Assumptions and Acronyms Used

24. Research Methodology

List of Tables

Table 01: Global Pigmented Lesion Treatment Market Value (US$ Mn) Analysis and Forecast 2017–2032, by Product

Table 02: Global Pigmented Lesion Treatment Market Volume (Units) Analysis and Forecast 2017–2032, by Product

Table 03: Global Pigmented Lesion Treatment Market Value (US$ Mn) Analysis and Forecast 2017–2032, by Lesion Type

Table 04: Global Pigmented Lesion Treatment Market Value (US$ Mn) Analysis and Forecast 2017–2032, by End User

Table 05: Global Pigmented Lesion Treatment Market Value (US$ Mn) Analysis and Forecast 2017–2032, by Region

Table 06: North America Pigmented Lesion Treatment Market Value (US$ Mn) Analysis 2017-2021 and Forecast 2022–2032, by Country

Table 07: North America Pigmented Lesion Treatment Market Value (US$ Mn) Analysis and Forecast 2017–2032, by Product

Table 08: North America Pigmented Lesion Treatment Market Volume (Units) Analysis and Forecast 2017–2032, by Product

Table 09: North America Pigmented Lesion Treatment Market Value (US$ Mn) Analysis and Forecast 2017–2032, by Lesion Type

Table 10: North America Pigmented Lesion Treatment Market Value (US$ Mn) Analysis and Forecast 2017–2032, by End User

Table 11: Latin America Pigmented Lesion Treatment Market Value (US$ Mn) Analysis 2017-2021 and Forecast 2022–2032, by Country

Table 12: Latin America Pigmented Lesion Treatment Market Value (US$ Mn) Analysis and Forecast 2017–2032, by Product

Table 13: Latin America Pigmented Lesion Treatment Market Volume (Units) Analysis and Forecast 2017–2032, by Product

Table 14: Latin America Pigmented Lesion Treatment Market Value (US$ Mn) Analysis and Forecast 2017–2032, by Lesion Type

Table 15: Latin America Pigmented Lesion Treatment Market Value (US$ Mn) Analysis and Forecast 2017–2032, by End User

Table 16: Europe Pigmented Lesion Treatment Market Value (US$ Mn) Analysis 2017-2021 and Forecast 2022–2032, by Country

Table 17: Europe Pigmented Lesion Treatment Market Value (US$ Mn) Analysis and Forecast 2017–2032, by Product

Table 18: Europe Pigmented Lesion Treatment Market Volume (Units) Analysis and Forecast 2017–2032, by Product

Table 19: Europe Pigmented Lesion Treatment Market Value (US$ Mn) Analysis and Forecast 2017–2032, by Lesion Type

Table 20: Europe Pigmented Lesion Treatment Market Value (US$ Mn) Analysis and Forecast 2017–2032, by End User

Table 21: South Asia Pigmented Lesion Treatment Market Value (US$ Mn) Analysis 2017-2021 and Forecast 2022–2032, by Country

Table 22: South Asia Pigmented Lesion Treatment Market Value (US$ Mn) Analysis and Forecast 2017–2032, by Product

Table 23: South Asia Pigmented Lesion Treatment Market Volume (Units) Analysis and Forecast 2017–2032, by Product

Table 24: South Asia Pigmented Lesion Treatment Market Value (US$ Mn) Analysis and Forecast 2017–2032, by Lesion Type

Table 25: South Asia Pigmented Lesion Treatment Market Value (US$ Mn) Analysis and Forecast 2017–2032, by End User

Table 26: East Asia Pigmented Lesion Treatment Market Value (US$ Mn) Analysis 2017-2021 and Forecast 2022–2032, by Country

Table 27: East Asia Pigmented Lesion Treatment Market Value (US$ Mn) Analysis and Forecast 2017–2032, by Product

Table 28: East Asia Pigmented Lesion Treatment Market Volume (Units) Analysis and Forecast 2017–2032, by Product

Table 29: East Asia Pigmented Lesion Treatment Market Value (US$ Mn) Analysis and Forecast 2017–2032, by Lesion Type

Table 30: East Asia Pigmented Lesion Treatment Market Value (US$ Mn) Analysis and Forecast 2017–2032, by End User

Table 31: Oceania Pigmented Lesion Treatment Market Value (US$ Mn) Analysis 2017-2021 and Forecast 2022–2032, by Country

Table 32: Oceania Pigmented Lesion Treatment Market Value (US$ Mn) Analysis and Forecast 2017–2032, by Product

Table 33: Oceania Pigmented Lesion Treatment Market Volume (Units) Analysis and Forecast 2017–2032, by Product

Table 34: Oceania Pigmented Lesion Treatment Market Value (US$ Mn) Analysis and Forecast 2017–2032, by Lesion Type

Table 35: Oceania Pigmented Lesion Treatment Market Value (US$ Mn) Analysis and Forecast 2017–2032, by End User

Table 36: MEA Pigmented Lesion Treatment Market Value (US$ Mn) Analysis 2017-2021 and Forecast 2022–2032, by Country

Table 37: MEA Pigmented Lesion Treatment Market Value (US$ Mn) Analysis and Forecast 2017–2032, by Product

Table 38: MEA Pigmented Lesion Treatment Market Volume (Units) Analysis and Forecast 2017–2032, by Product

Table 39: MEA Pigmented Lesion Treatment Market Value (US$ Mn) Analysis and Forecast 2017–2032, by Lesion Type

Table 40: MEA Pigmented Lesion Treatment Market Value (US$ Mn) Analysis and Forecast 2017–2032, by End User

Sabyasachi Ghosh

Principal Consultant

Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst

List of Charts

Figure 01: Global Pigmented Lesion Treatment Market Volume (Units), 2017 – 2021

Figure 02: Global Pigmented Lesion Treatment Market Volume (Units) & Y-o-Y Growth (%) Analysis, 2022–2032

Figure 03: Excimer and Femtosecond Ophthalmic Laser, Pricing Analysis per unit (US$), in 2022

Figure 04: Excimer and Femtosecond Ophthalmic Laser, Pricing Forecast per unit (US$), in 2032

Figure 05: Global Excimer and Femtosecond Ophthalmology Laser Market Value (US$ Mn) Analysis, 2017–2021

Figure 06: Global Pigmented Lesion Treatment Market Forecast & Y-o-Y Growth, 2022–2032

Figure 07: Global Pigmented Lesion Treatment Market Absolute $ Opportunity (US$ Mn) Analysis, 2021–2032

Figure 08: Global Pigmented Lesion Treatment Market Value Share (%) Analysis 2022 and 2032, by Product

Figure 09: Global Pigmented Lesion Treatment Market Y-o-Y Growth (%) Analysis 2021-2032, by Product

Figure 10: Global Pigmented Lesion Treatment Market Attractiveness Analysis 2022–2032, by Product

Figure 11: Global Pigmented Lesion Treatment Market Value Share (%) Analysis 2022 and 2032, by Lesion Type

Figure 12: Global Pigmented Lesion Treatment Market Y-o-Y Growth (%) Analysis 2021-2032, by Lesion Type

Figure 13: Global Pigmented Lesion Treatment Market Attractiveness Analysis 2022–2032, by Lesion Type

Figure 14: Global Pigmented Lesion Treatment Market Value Share (%) Analysis 2022 and 2032, by End User

Figure 15: Global Pigmented Lesion Treatment Market Y-o-Y Growth (%) Analysis 2021-2032, by End User

Figure 16: Global Pigmented Lesion Treatment Market Attractiveness Analysis 2022–2032, by End User

Figure 17: Global Pigmented Lesion Treatment Market Value Share (%) Analysis 2022 and 2032, by Region

Figure 18: Global Pigmented Lesion Treatment Market Y-o-Y Growth (%) Analysis 2021-2032, by Region

Figure 19: Global Pigmented Lesion Treatment Market Attractiveness Analysis 2022–2032, by Region

Figure 20: North America Pigmented Lesion Treatment Market Value (US$ Mn) Analysis, 2017–2021

Figure 21: North America Pigmented Lesion Treatment Market Value (US$ Mn) Forecast, 2022-2032

Figure 22: North America Pigmented Lesion Treatment Market Value Share, by Product (2022 E)

Figure 23: North America Pigmented Lesion Treatment Market Value Share, by Lesion Type(2022 E)

Figure 24: North America Pigmented Lesion Treatment Market Value Share, by End User (2022 E)

Figure 25: North America Pigmented Lesion Treatment Market Value Share, by Country (2022 E)

Figure 26: North America Pigmented Lesion Treatment Market Attractiveness Analysis by Product, 2022–2032

Figure 27: North America Pigmented Lesion Treatment Market Attractiveness Analysis by Lesion Type, 2022–2032

Figure 28: North America Pigmented Lesion Treatment Market Attractiveness Analysis by End User, 2022–2032

Figure 29: North America Pigmented Lesion Treatment Market Attractiveness Analysis by Country, 2022–2032

Figure 30: U.S. Pigmented Lesion Treatment Market Value Proportion Analysis, 2021

Figure 31: Global Vs. U.S. Growth Comparison 2021-2032

Figure 32: U.S. Pigmented Lesion Treatment Market Share Analysis (%) by Product, 2022 & 2032

Figure 33: U.S. Pigmented Lesion Treatment Market Share Analysis (%) by Lesion Type, 2022 & 2032

Figure 34: U.S. Pigmented Lesion Treatment Market Share Analysis (%) by End User, 2022 & 2032

Figure 35: Canada Pigmented Lesion Treatment Market Value Proportion Analysis, 2021

Figure 36: Global Vs. Canada. Growth Comparison 2021-2032

Figure 37: Canada Pigmented Lesion Treatment Market Share Analysis (%) by Product, 2022 & 2032

Figure 38: Canada Pigmented Lesion Treatment Market Share Analysis (%) by Lesion Type, 2022 & 2032

Figure 39: Canada Pigmented Lesion Treatment Market Share Analysis (%) by End User, 2022 & 2032

Figure 40: Latin America Pigmented Lesion Treatment Market Value (US$ Mn) Analysis, 2017–2021

Figure 41: Latin America Pigmented Lesion Treatment Market Value (US$ Mn) Forecast, 2022-2032

Figure 42: Latin America Pigmented Lesion Treatment Market Value Share, by Product (2022 E)

Figure 43: Latin America Pigmented Lesion Treatment Market Value Share, by Lesion Type(2022 E)

Figure 44: Latin America Pigmented Lesion Treatment Market Value Share, by End User (2022 E)

Figure 45: Latin America Pigmented Lesion Treatment Market Value Share, by Country (2022 E)

Figure 46: Latin America Pigmented Lesion Treatment Market Attractiveness Analysis by Product, 2022–2032

Figure 47: Latin America Pigmented Lesion Treatment Market Attractiveness Analysis by Lesion Type, 2022–2032

Figure 48: Latin America Pigmented Lesion Treatment Market Attractiveness Analysis by End User, 2022–2032

Figure 49: Latin America Pigmented Lesion Treatment Market Attractiveness Analysis by Country, 2022–2032

Figure 50: Mexico Pigmented Lesion Treatment Market Value Proportion Analysis, 2021

Figure 51: Global Vs Mexico Growth Comparison 2021-2032

Figure 52: Mexico Pigmented Lesion Treatment Market Share Analysis (%) by Product, 2022 & 2032

Figure 53: Mexico Pigmented Lesion Treatment Market Share Analysis (%) by Lesion Type, 2022 & 2032

Figure 54: Mexico Pigmented Lesion Treatment Market Share Analysis (%) by End User, 2022 & 2032

Figure 55: Brazil Pigmented Lesion Treatment Market Value Proportion Analysis, 2021

Figure 56: Global Vs. Brazil. Growth Comparison 2021-2032

Figure 57: Brazil Pigmented Lesion Treatment Market Share Analysis (%) by Product, 2022 & 2032

Figure 58: Brazil Pigmented Lesion Treatment Market Share Analysis (%) by Lesion Type, 2022 & 2032

Figure 59: Brazil Pigmented Lesion Treatment Market Share Analysis (%) by End User, 2022 & 2032

Figure 60: Argentina Pigmented Lesion Treatment Market Value Proportion Analysis, 2021

Figure 61: Global Vs Argentina Growth Comparison 2021-2032

Figure 62: Argentina Pigmented Lesion Treatment Market Share Analysis (%) by Product, 2022 & 2032

Figure 63: Argentina Pigmented Lesion Treatment Market Share Analysis (%) by Lesion Type, 2022 & 2032

Figure 64: Argentina Pigmented Lesion Treatment Market Share Analysis (%) by End User, 2022 & 2032

Figure 65: Europe Pigmented Lesion Treatment Market Value (US$ Mn) Analysis, 2017–2021

Figure 66: Europe Pigmented Lesion Treatment Market Value (US$ Mn) Forecast, 2022-2032

Figure 67: Europe Pigmented Lesion Treatment Market Value Share, by Product (2022 E)

Figure 68: Europe Pigmented Lesion Treatment Market Value Share, by Lesion Type(2022 E)

Figure 69: Europe Pigmented Lesion Treatment Market Value Share, by End User (2022 E)

Figure 70: Europe Pigmented Lesion Treatment Market Value Share, by Country (2022 E)

Figure 71: Europe Pigmented Lesion Treatment Market Attractiveness Analysis by Product, 2022–2032

Figure 72: Europe Pigmented Lesion Treatment Market Attractiveness Analysis by Lesion Type, 2022–2032

Figure 73: Europe Pigmented Lesion Treatment Market Attractiveness Analysis by End User, 2022–2032

Figure 74: Europe Pigmented Lesion Treatment Market Attractiveness Analysis by Country, 2022–2032

Figure 75: UK Pigmented Lesion Treatment Market Value Proportion Analysis, 2021

Figure 76: Global Vs. UK Growth Comparison 2021-2032

Figure 77: UK Pigmented Lesion Treatment Market Share Analysis (%) by Product, 2022 & 2032

Figure 78: UK Pigmented Lesion Treatment Market Share Analysis (%) by Lesion Type, 2022 & 2032

Figure 79: UK Pigmented Lesion Treatment Market Share Analysis (%) by End User, 2022 & 2032

Figure 80: Germany Pigmented Lesion Treatment Market Value Proportion Analysis, 2021

Figure 81: Global Vs. Germany Growth Comparison 2021-2032

Figure 82: Germany Pigmented Lesion Treatment Market Share Analysis (%) by Product, 2022 & 2032

Figure 83: Germany Pigmented Lesion Treatment Market Share Analysis (%) by Lesion Type, 2022 & 2032

Figure 84: Germany Pigmented Lesion Treatment Market Share Analysis (%) by End User, 2022 & 2032

Figure 85: Italy Pigmented Lesion Treatment Market Value Proportion Analysis, 2021

Figure 86: Global Vs. Italy Growth Comparison 2021-2032

Figure 87: Italy Pigmented Lesion Treatment Market Share Analysis (%) by Product, 2022 & 2032

Figure 88: Italy Pigmented Lesion Treatment Market Share Analysis (%) by Lesion Type, 2022 & 2032

Figure 89: Italy Pigmented Lesion Treatment Market Share Analysis (%) by End User, 2022 & 2032

Figure 90: France Pigmented Lesion Treatment Market Value Proportion Analysis, 2021

Figure 91: Global Vs France Growth Comparison 2021-2032

Figure 92: France Pigmented Lesion Treatment Market Share Analysis (%) by Product, 2022 & 2032

Figure 93: France Pigmented Lesion Treatment Market Share Analysis (%) by Lesion Type, 2022 & 2032

Figure 94: France Pigmented Lesion Treatment Market Share Analysis (%) by End User, 2022 & 2032

Figure 95: Spain Pigmented Lesion Treatment Market Value Proportion Analysis, 2021

Figure 96: Global Vs Spain Growth Comparison 2021-2032

Figure 97: Spain Pigmented Lesion Treatment Market Share Analysis (%) by Product, 2022 & 2032

Figure 98: Spain Pigmented Lesion Treatment Market Share Analysis (%) by Lesion Type, 2022 & 2032

Figure 99: Spain Pigmented Lesion Treatment Market Share Analysis (%) by End User, 2022 & 2032

Figure 100: Russia Pigmented Lesion Treatment Market Value Proportion Analysis, 2021

Figure 101: Global Vs Russia Growth Comparison 2021-2032

Figure 102: Russia Pigmented Lesion Treatment Market Share Analysis (%) by Product, 2022 & 2032

Figure 103: Russia Pigmented Lesion Treatment Market Share Analysis (%) by Lesion Type, 2022 & 2032

Figure 104: Russia Pigmented Lesion Treatment Market Share Analysis (%) by End User, 2022 & 2032

Figure 105: BENELUX Pigmented Lesion Treatment Market Value Proportion Analysis, 2021

Figure 106: Global Vs BENELUX Growth Comparison 2021-2032

Figure 107: BENELUX Pigmented Lesion Treatment Market Share Analysis (%) by Product, 2022 & 2032

Figure 108: BENELUX Pigmented Lesion Treatment Market Share Analysis (%) by Lesion Type, 2022 & 2032

Figure 109: BENELUX Pigmented Lesion Treatment Market Share Analysis (%) by End User, 2022 & 2032

Figure 110: Nordic Countries Pigmented Lesion Treatment Market Value Proportion Analysis, 2021

Figure 111: Global Vs Nordic Countries Growth Comparison 2021-2032

Figure 112: Nordic Countries Pigmented Lesion Treatment Market Share Analysis (%) by Product, 2022 & 2032

Figure 113: Nordic Countries Pigmented Lesion Treatment Market Share Analysis (%) by Lesion Type, 2022 & 2032

Figure 114: Nordic Countries Pigmented Lesion Treatment Market Share Analysis (%) by End User, 2022 & 2032

Figure 115: East Asia Pigmented Lesion Treatment Market Value (US$ Mn) Analysis, 2017–2021

Figure 116: East Asia Pigmented Lesion Treatment Market Value (US$ Mn) Forecast, 2022-2032

Figure 117: East Asia Pigmented Lesion Treatment Market Value Share, by Product (2022 E)

Figure 118: East Asia Pigmented Lesion Treatment Market Value Share, by Lesion Type(2022 E)

Figure 119: East Asia Pigmented Lesion Treatment Market Value Share, by End User (2022 E)

Figure 120: East Asia Pigmented Lesion Treatment Market Value Share, by Country (2022 E)

Figure 121: East Asia Pigmented Lesion Treatment Market Attractiveness Analysis by Product, 2022–2032

Figure 122: East Asia Pigmented Lesion Treatment Market Attractiveness Analysis by Lesion Type, 2022–2032

Figure 123: East Asia Pigmented Lesion Treatment Market Attractiveness Analysis by End User, 2022–2032

Figure 124: East Asia Pigmented Lesion Treatment Market Attractiveness Analysis by Country, 2022–2032

Figure 125: China Pigmented Lesion Treatment Market Value Proportion Analysis, 2021

Figure 126: Global Vs. China Growth Comparison 2021-2032

Figure 127: China Pigmented Lesion Treatment Market Share Analysis (%) by Product, 2022 & 2032

Figure 128: China Pigmented Lesion Treatment Market Share Analysis (%) by Lesion Type, 2022 & 2032

Figure 129: China Pigmented Lesion Treatment Market Share Analysis (%) by End User, 2022 & 2032

Figure 130: Japan Pigmented Lesion Treatment Market Value Proportion Analysis, 2021

Figure 131: Global Vs. Japan Growth Comparison 2021-2032

Figure 132: Japan Pigmented Lesion Treatment Market Share Analysis (%) by Product, 2022 & 2032

Figure 133: Japan Pigmented Lesion Treatment Market Share Analysis (%) by Lesion Type, 2022 & 2032

Figure 134: Japan Pigmented Lesion Treatment Market Share Analysis (%) by End User, 2022 & 2032

Figure 135: South Korea Pigmented Lesion Treatment Market Value Proportion Analysis, 2021

Figure 136: Global Vs South Korea Growth Comparison 2021-2032

Figure 137: South Korea Pigmented Lesion Treatment Market Share Analysis (%) by Product, 2022 & 2032

Figure 138: South Korea Pigmented Lesion Treatment Market Share Analysis (%) by Lesion Type, 2022 & 2032

Figure 139: South Korea Pigmented Lesion Treatment Market Share Analysis (%) by End User, 2022 & 2032

Figure 140: South Asia Pigmented Lesion Treatment Market Value (US$ Mn) Analysis, 2017–2021

Figure 141: South Asia Pigmented Lesion Treatment Market Value (US$ Mn) Forecast, 2022-2032

Figure 142: South Asia Pigmented Lesion Treatment Market Value Share, by Product (2022 E)

Figure 143: South Asia Pigmented Lesion Treatment Market Value Share, by Lesion Type(2022 E)

Figure 144: South Asia Pigmented Lesion Treatment Market Value Share, by End User (2022 E)

Figure 145: South Asia Pigmented Lesion Treatment Market Value Share, by Country (2022 E)

Figure 146: South Asia Pigmented Lesion Treatment Market Attractiveness Analysis by Product, 2022–2032

Figure 147: South Asia Pigmented Lesion Treatment Market Attractiveness Analysis by Lesion Type, 2022–2032

Figure 148: South Asia Pigmented Lesion Treatment Market Attractiveness Analysis by End User, 2022–2032

Figure 149: South Asia Pigmented Lesion Treatment Market Attractiveness Analysis by Country, 2022–2032

Figure 150: India Pigmented Lesion Treatment Market Value Proportion Analysis, 2021

Figure 151: Global Vs. India Growth Comparison 2021-2032

Figure 152: India Pigmented Lesion Treatment Market Share Analysis (%) by Product, 2022 & 2032

Figure 153: India Pigmented Lesion Treatment Market Share Analysis (%) by Lesion Type, 2022 & 2032

Figure 154: India Pigmented Lesion Treatment Market Share Analysis (%) by End User, 2022 & 2032

Figure 155: Indonesia Pigmented Lesion Treatment Market Value Proportion Analysis, 2021

Figure 156: Global Vs. Indonesia Growth Comparison 2021-2032

Figure 157: Indonesia Pigmented Lesion Treatment Market Share Analysis (%) by Product, 2022 & 2032

Figure 158: Indonesia Pigmented Lesion Treatment Market Share Analysis (%) by Lesion Type, 2022 & 2032

Figure 159: Indonesia Pigmented Lesion Treatment Market Share Analysis (%) by End User, 2022 & 2032

Figure 160: Malaysia Pigmented Lesion Treatment Market Value Proportion Analysis, 2021

Figure 161: Global Vs. Malaysia Growth Comparison 2021-2032

Figure 162: Malaysia Pigmented Lesion Treatment Market Share Analysis (%) by Product, 2022 & 2032

Figure 163: Malaysia Pigmented Lesion Treatment Market Share Analysis (%) by Lesion Type, 2022 & 2032

Figure 164: Malaysia Pigmented Lesion Treatment Market Share Analysis (%) by End User, 2022 & 2032

Figure 165: Thailand Pigmented Lesion Treatment Market Value Proportion Analysis, 2021

Figure 166: Global Vs. Thailand Growth Comparison 2021-2032

Figure 167: Thailand Pigmented Lesion Treatment Market Share Analysis (%) by Product, 2022 & 2032

Figure 168: Thailand Pigmented Lesion Treatment Market Share Analysis (%) by Lesion Type, 2022 & 2032

Figure 169: Thailand Pigmented Lesion Treatment Market Share Analysis (%) by End User, 2022 & 2032

Figure 170: Philippines Pigmented Lesion Treatment Market Value Proportion Analysis, 2021

Figure 171: Global Vs. Philippines Growth Comparison 2021-2032

Figure 172: Philippines Pigmented Lesion Treatment Market Share Analysis (%) by Product, 2022 & 2032

Figure 173: Philippines Pigmented Lesion Treatment Market Share Analysis (%) by Lesion Type, 2022 & 2032

Figure 174: Philippines Pigmented Lesion Treatment Market Share Analysis (%) by End User, 2022 & 2032

Figure 175: Vietnam Pigmented Lesion Treatment Market Value Proportion Analysis, 2021

Figure 176: Global Vs. Vietnam Growth Comparison 2021-2032

Figure 177: Vietnam Pigmented Lesion Treatment Market Share Analysis (%) by Product, 2022 & 2032

Figure 178: Vietnam Pigmented Lesion Treatment Market Share Analysis (%) by Lesion Type, 2022 & 2032

Figure 179: Vietnam Pigmented Lesion Treatment Market Share Analysis (%) by End User, 2022 & 2032

Figure 180: Oceania Pigmented Lesion Treatment Market Value (US$ Mn) Analysis, 2017–2021

Figure 181: Oceania Pigmented Lesion Treatment Market Value (US$ Mn) Forecast, 2022-2032

Figure 182: Oceania Pigmented Lesion Treatment Market Value Share, by Product (2022 E)

Figure 183: Oceania Pigmented Lesion Treatment Market Value Share, by Lesion Type(2022 E)

Figure 184: Oceania Pigmented Lesion Treatment Market Value Share, by End User (2022 E)

Figure 185: Oceania Pigmented Lesion Treatment Market Value Share, by Country (2022 E)

Figure 186: Oceania Pigmented Lesion Treatment Market Attractiveness Analysis by Product, 2022–2032

Figure 187: Oceania Pigmented Lesion Treatment Market Attractiveness Analysis by Lesion Type, 2022–2032

Figure 188: Oceania Pigmented Lesion Treatment Market Attractiveness Analysis by End User, 2022–2032

Figure 189: Oceania Pigmented Lesion Treatment Market Attractiveness Analysis by Country, 2022–2032

Figure 190: Australia Pigmented Lesion Treatment Market Value Proportion Analysis, 2021

Figure 191: Global Vs. Australia Growth Comparison 2021-2032

Figure 192: Australia Pigmented Lesion Treatment Market Share Analysis (%) by Product, 2022 & 2032

Figure 193: Australia Pigmented Lesion Treatment Market Share Analysis (%) by Lesion Type, 2022 & 2032

Figure 194: Australia Pigmented Lesion Treatment Market Share Analysis (%) by End User, 2022 & 2032

Figure 195: New Zealand Pigmented Lesion Treatment Market Value Proportion Analysis, 2021

Figure 196: Global Vs New Zealand Growth Comparison 2021-2032

Figure 197: New Zealand Pigmented Lesion Treatment Market Share Analysis (%) by Product, 2022 & 2032

Figure 198: New Zealand Pigmented Lesion Treatment Market Share Analysis (%) by Lesion Type, 2022 & 2032

Figure 199: New Zealand Pigmented Lesion Treatment Market Share Analysis (%) by End User, 2022 & 2032

Figure 200: Middle East & Africa Pigmented Lesion Treatment Market Value (US$ Mn) Analysis, 2017–2021

Figure 201: Middle East & Africa Pigmented Lesion Treatment Market Value (US$ Mn) Forecast, 2022-2032

Figure 202: Middle East & Africa Pigmented Lesion Treatment Market Value Share, by Product (2022 E)

Figure 203: Middle East & Africa Pigmented Lesion Treatment Market Value Share, by Lesion Type(2022 E)

Figure 204: Middle East & Africa Pigmented Lesion Treatment Market Value Share, by End User (2022 E)

Figure 205: Middle East & Africa Pigmented Lesion Treatment Market Value Share, by Country (2022 E)

Figure 206: Middle East & Africa Pigmented Lesion Treatment Market Attractiveness Analysis by Product, 2022–2032

Figure 207: Middle East & Africa Pigmented Lesion Treatment Market Attractiveness Analysis by Lesion Type, 2022–2032

Figure 208: Middle East & Africa Pigmented Lesion Treatment Market Attractiveness Analysis by End User, 2022–2032

Figure 209: Middle East & Africa Pigmented Lesion Treatment Market Attractiveness Analysis by Country, 2022–2032

Figure 210: GCC Countries Pigmented Lesion Treatment Market Value Proportion Analysis, 2021

Figure 211: Global Vs GCC Countries Growth Comparison 2021-2032

Figure 212: GCC Countries Pigmented Lesion Treatment Market Share Analysis (%) by Product, 2022 & 2032

Figure 213: GCC Countries Pigmented Lesion Treatment Market Share Analysis (%) by Lesion Type, 2022 & 2032

Figure 214: GCC Countries Pigmented Lesion Treatment Market Share Analysis (%) by End User, 2022 & 2032

Figure 215: Turkey Pigmented Lesion Treatment Market Value Proportion Analysis, 2021

Figure 216: Global Vs. Turkey Growth Comparison 2021-2032

Figure 217: Turkey Pigmented Lesion Treatment Market Share Analysis (%) by Product, 2022 & 2032

Figure 218: Turkey Pigmented Lesion Treatment Market Share Analysis (%) by Lesion Type, 2022 & 2032

Figure 219: Turkey Pigmented Lesion Treatment Market Share Analysis (%) by End User, 2022 & 2032

Figure 220: Israel Pigmented Lesion Treatment Market Value Proportion Analysis, 2021

Figure 221: Global Vs. Israel Growth Comparison 2021-2032

Figure 222: Israel Pigmented Lesion Treatment Market Share Analysis (%) by Product, 2022 & 2032

Figure 223: Israel Pigmented Lesion Treatment Market Share Analysis (%) by Lesion Type, 2022 & 2032

Figure 224: Israel Pigmented Lesion Treatment Market Share Analysis (%) by End User, 2022 & 2032

Figure 225: South Africa Pigmented Lesion Treatment Market Value Proportion Analysis, 2021

Figure 226: Global Vs. South Africa Growth Comparison 2021-2032

Figure 227: South Africa Pigmented Lesion Treatment Market Share Analysis (%) by Product, 2022 & 2032

Figure 228: South Africa Pigmented Lesion Treatment Market Share Analysis (%) by Lesion Type, 2022 & 2032

Figure 229: South Africa Pigmented Lesion Treatment Market Share Analysis (%) by End User, 2022 & 2032

Figure 230: North Africa Pigmented Lesion Treatment Market Value Proportion Analysis, 2021

Figure 231: Global Vs North Africa Growth Comparison 2021-2032

Figure 232: North Africa Pigmented Lesion Treatment Market Share Analysis (%) by Product, 2022 & 2032

Figure 233: North Africa Pigmented Lesion Treatment Market Share Analysis (%) by Lesion Type, 2022 & 2032

Figure 234North Africa Pigmented Lesion Treatment Market Share Analysis (%) by End User, 2022 & 2032